Genus Share News (GNS)

Genus' ABS unit has 'challenging start' to FY, PIC trading remains 'robust'

(Sharecast News) - Animal genetics firm Genus said its ABS division has had "a challenging start" to the year but noted that PIC trading in the roughly five months ended 21 November had been "robust".

UK shareholder meetings calendar - next 7 days

UK dividends calendar - next 7 days

Genus gets Colombia approval for pigs resistant to a specific virus

(Alliance News) - Genus PLC on Thursday said the Colombian government has given a favourable regulatory determination for Genus's PRRS virus-resistant pigs.

Genus annual profit plunges but revenue surges on regional growth

(Alliance News) - Genus PLC on Thursday posted a drop in annual profit on higher costs, but said growth across all regions drove an increase in revenue.

Genus full-year revenue rises, profits remain static

(Sharecast News) - Agricultural biotechnology firm Genus reported 10% growth in group revenue in its preliminary results on Thursday, to £689.7m, or 16% when translated to constant currency rates.

UK earnings, trading statements calendar - next 7 days

LONDON MARKET MIDDAY: Stocks subdued; US debt ceiling concern weighs

(Alliance News) - Stock prices in London were directionless at midday on Tuesday as markets digested the latest UK unemployment data and nervously eyed incoming US debt ceiling crunch talks.

Genus expects China business to swing to loss on weak porcine markets

(Alliance News) - Genus PLC on Tuesday said it expects its Chinese division to swing to a loss in the second half of the year, amid uncertainty over when porcine markets will recover.

LONDON MARKET OPEN: Stocks drift up amid unease over US debt talks

(Alliance News) - Stock prices in London edged into the green at Tuesday's open, but investors failed to muster much enthusiasm following weak Chinese economic data and fears of a US debt default.

Genus cuts full-year profit outlook

(Sharecast News) - Animal genetics company Genus cut its full-year profit outlook on Tuesday as it pointed to "very challenging" market conditions in the porcine business in China.

Director dealings: Genus announces new CEO's compensation, AstraZeneca chair spends £0.23m

(Sharecast News) - Livestock genetics company Genus saw its shares weaken on Tuesday afternoon after it announced the agreed reward arrangements for its incoming CEO, Jorgen Kokke.

Genus appoints Ingredion's Jorgen Kokke as CEO designate

(Alliance News) - Genus PLC announced on Monday the appointment of Jorgen Kokke as chief executive officer designate effective May 2.

LONDON BRIEFING: Stocks open higher ahead of PMI readings

(Alliance News) - Stocks in London opened higher on Monday morning, ahead of a slew of PMI scores in Europe and the US, whilst oil prices surged after a surprise Opec production cut.

Genus names Jorgen Kokke as its next CEO

(Sharecast News) - Animal genetics company Genus announced the appointment of Jorgen Kokke as its chief executive officer-designate on Monday, with plans to take over as CEO on 1 July, succeeding Stephen Wilson, who would retire on 30 September.